Skip to Content

Nichi-Iko Pharmaceutical Co Ltd NHKFF

Morningstar Rating
$0.36 −25.27 Mil (100.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

NHKFF is trading at a 735% premium.
Price
$0.36
Fair Value
$3.78
Uncertainty
Extreme
1-Star Price
$1.84
5-Star Price
$4.85
Economic Moat
Fcnwzl
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if NHKFF is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.35
Day Range
$0.360.36
52-Week Range
$24.63 Mil323.77 Mil
Bid/Ask
$0.00 / $53,835.26
Market Cap
$25.29 Mil
Volume/Avg
5,000 / 0

Key Statistics

Price/Earnings (Normalized)
Price/Sales
0.02
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Nichi-Iko Pharmaceutical Co Ltd is a major drug manufacturing company in Japan. Its core business includes the manufacture and sale of generic pharmaceutical products, through sales to pharmaceutical wholesalers and medical institutions. The vast majority of the company's sales are derived from prescription drugs. The company operates various subsidiaries across an array of other countries, including Thailand.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Value
Total Number of Employees
3,380

Valuation

Metric
NHKFF
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
0.02
Price/Cash Flow
Price/Earnings
NHKFF

Financial Strength

Metric
NHKFF
Quick Ratio
0.46
Current Ratio
0.89
Interest Coverage
−71.91
Quick Ratio
NHKFF

Profitability

Metric
NHKFF
Return on Assets (Normalized)
−11.72%
Return on Equity (Normalized)
−399.83%
Return on Invested Capital (Normalized)
−17.45%
Return on Assets
NHKFF
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Zoetis Inc Class A
ZTS
NtytxvljLqcm$81.7 Bil
Merck KGaA ADR
MKKGY
ZpmcrgddysHjncz$72.9 Bil
Haleon PLC ADR
HLN
ZxmqstmjKlfxj$39.8 Bil
Dr Reddy's Laboratories Ltd ADR
RDY
GbtgpfkvCbtf$13.4 Bil
Viatris Inc
VTRS
PcxplbjhfWbl$13.4 Bil
Catalent Inc
CTLT
QmmskyvqYzmmyh$10.4 Bil
Perrigo Co PLC
PRGO
LjglcrgcsVhc$3.7 Bil
Prestige Consumer Healthcare Inc
PBH
SmcyynshDhdznn$3.5 Bil
Curaleaf Holdings Inc
CURLF
PmzzcxdhxXrts$3.1 Bil
Green Thumb Industries Inc
GTBIF
TtjwpjvnltJdsn$2.8 Bil

Sponsor Center